Jerry Colca

Jerry Colca

Company: Cirius Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Deliberating the Next Steps Towards the Identification & Application of Non-Invasive Biomarkers for NASH 2:00 pm

Discussing appropriate biomarkers for patients’ segmentation and better understanding heterogeneity Maximizing treatment responsiveness by leveraging predictive biomarkers (responder vs non-responder) Efforts on linking NITs to clinical outcome/benefitsRead more

day: Seminar B PM tracks

New Metabolic Target & Metabolic Marker Suggest a Way Forward in Metabolic Associated Steatotic Liver Disease (MASLD) 1:00 pm

New view of the pathophysiology of MASLD/MASH: further examing Phase 2b data for an insulin sensitizer with a newly appreciated mitochondrial target Fasting hyperinsulinemia as an addressable marker for reduced liver function leading to disease progression Exploring metabolic reprogramming in multiple cell types to address multi-organ involvement in the pathologyRead more

day: Seminar B PM tracks

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.